Effectiveness and safety of morinidazole in the treatment of pelvic inflammatory disease: A multicenter, prospective, open-label phase IV trial

BACKGROUND: Antimicrobial resistance to metronidazole has emerged after several decades of worldwide use of the drug. The purpose of this study was to evaluate the effectiveness, safety and population pharmacokinetics of morinidazole plus levofloxacin in adult women with pelvic inflammatory disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ting, Yuan, Ming, Cui, Pengfei, Li, Jingjing, Jia, Feifei, Wang, Shixuan, Liu, Ronghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382104/
https://www.ncbi.nlm.nih.gov/pubmed/35991648
http://dx.doi.org/10.3389/fmed.2022.888186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382104/
https://www.ncbi.nlm.nih.gov/pubmed/35991648
http://dx.doi.org/10.3389/fmed.2022.888186

Ejemplares similares